TrialLancet (London, England)2018

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.

Zhi-Wei Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.